✦ LIBER ✦

456 Safety, pharmacokinetics and pharmacodynamic results of higher doses of albuferon in a phase 12 single and double dose-escalation study in treatment experienced subjects with chronic hepatitis C

✍ Scribed by V. Balan; M. Sulkowski; D. Nelson; G. Everson; R. Dickson; L. Lambiase; A. Post; R. Redfield; R. Wiesner; J. Recta; B. Osborn; L. Novello; W. Freimuth; M. Subramanian

Book ID: 117373285
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 63 KB
Volume: 40
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(04)90456-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

313 A 1/2phase study to evaluate the pha

313 A 1/2phase study to evaluate the pharmacokinetics, safety, tolerability, immunogenicity, and pharmacodynamics of albuferon™ in the treatment experienced subjects with chronic hepatitis C

✍ V. Balan; M. Sulkowski; D. Nelson; G. Everson; T. Bambury; J. Recta; J. Zhong; H 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB

737 A PHASE-I, RANDOMIZED, DOUBLE-BLIND,

737 A PHASE-I, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF SINGLE ESCALATING ORAL DOSES OF GS-9620 IN HEALTHY SUBJECTS

✍ U. Lopatin; G. Wolfgang; R. Kimberlin; D. Turnas; M. Cornprost; G. Chittick; C. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 46 KB

18 A phase 2 study to assess antiviral r

18 A phase 2 study to assess antiviral response, safety, and pharmacokinetics of albuferon™ in IFN-α NA1VE subjects with genotype 1 chronic hepatitis C

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 135 KB

A phase 1, randomized, double-blind, pla

A phase 1, randomized, double-blind, placebo-controlled dose-escalating, safety, tolerability, pharmacokinetic, and pharmacodynamic study of oral recombinant human interleukin eleven (O-rhIl-11) in normal healthy subjects

✍ Cotreau, Monette M.; Stonis, Lucille; Schwertschlag, Ullrich S. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 170 KB

A placebo-controlled, double-blind, dose

A placebo-controlled, double-blind, dose-escalation study to assess the safety, tolerability and pharmacokinetics/pharmacodynamics of single and multiple intravenous infusions of AZD9773 in patients with severe sepsis and septic shock

✍ Peter E Morris; Brian Zeno; Andrew C Bernard; Xiangning Huang; Shampa Das; Timi 📂 Article 📅 2012 🏛 Springer (Biomed Central Ltd.) 🌐 English ⚖ 300 KB

A Double-Blind, Randomized Placebo-Contr

A Double-Blind, Randomized Placebo-Controlled Phase II Study of the Pharmacodynamics, Safety/Tolerability, and Pharmacokinetics of Single Doses of the Motilin Agonist GSK962040, in Patients With Type I Diabetes Mellitus (T1DM) and Gastroparesis

✍ Hellström, Per M. ;Tack, Jan F. ;Stephens, Kimberley E. ;Barton, Matthew E. ;Vas 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 102 KB